Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.82 USD | +1.04% | +2.40% | +12.36% |
Financials (USD)
Sales 2024 * | 2.67B | Sales 2025 * | 2.79B | Capitalization | 2.11B |
---|---|---|---|---|---|
Net income 2024 * | -84M | Net income 2025 * | 23M | EV / Sales 2024 * | 1.67 x |
Net Debt 2024 * | 2.35B | Net Debt 2025 * | 2.12B | EV / Sales 2025 * | 1.52 x |
P/E ratio 2024 * |
-25.3
x | P/E ratio 2025 * |
97.4
x | Employees | 7,850 |
Yield 2024 * |
0.44% | Yield 2025 * |
-
| Free-Float | 26.12% |
Latest transcript on Amneal Pharmaceuticals, Inc.
1 day | +1.04% | ||
1 week | +2.40% | ||
Current month | +12.73% | ||
1 month | +27.24% | ||
3 months | +15.59% | ||
6 months | +50.55% | ||
Current year | +12.36% |
Managers | Title | Age | Since |
---|---|---|---|
Chirag K. Patel
FOU | Founder | 57 | 01-12-31 |
Chintu Patel
FOU | Founder | 53 | 01-12-31 |
Director of Finance/CFO | 57 | Nov. 06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ted Nark
BRD | Director/Board Member | 66 | Nov. 06 |
J. Buchi
BRD | Director/Board Member | 69 | Nov. 06 |
Paul Meister
CHM | Chairman | 71 | Nov. 06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 6.82 | +1.04% | 1,093,667 |
24-05-16 | 6.75 | -1.75% | 1,056,993 |
24-05-15 | 6.87 | +0.29% | 1,080,390 |
24-05-14 | 6.85 | +2.09% | 1,649,845 |
24-05-13 | 6.71 | +0.75% | 1,147,431 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.36% | 2.11B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- AMRX Stock